Related Experiment Video
Updated: Aug 22, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
Katsuyuki Iida1, Ken Itoh, Yoshito Kumagai
1Department of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Abstract:
The induction of phase 2 detoxifying enzymes, such as UDP-glucuronosyltransferases (UGTs), in response to an array of naturally occurring and synthetic agents, such as oltipraz (4-methyl-5-[2-pyrazinyl]-1,2-dithiole-3-thione), provides an effective means of protection against a variety of carcinogens. Transcription factor Nrf2 is an essential regulator of the inducible expression of detoxifying enzyme genes by chemopreventive agents. In this study, we investigated in Nrf2-deficient mice the susceptibility to the urinary bladder-specific carcinogen N-nitrosobutyl(4-hydroxybutyl)amine (BBN) and the chemopreventive efficacy of oltipraz. The incidence of urinary bladder carcinoma by BBN was significantly higher in Nrf2-/- mice than in wild-type mice; invasive carcinoma was found in 24.0 and 38.5% of wild-type and Nrf2-/- mice, respectively. Oltipraz induced the phase 2 enzymes responsible for BBN detoxification in the liver and urinary bladder in an Nrf2-dependent manner. As expected, therefore, oltipraz decreased the incidence of urinary bladder carcinoma by BBN in wild-type mice but had little effect in Nrf2-/- mice. In wild-type mouse liver, oltipraz significantly induced BBN glucuronidation and decreased the urinary concentration of N-nitrosobutyl(3-carboxypropyl)amine, a proximate carcinogen of BBN. Importantly, BBN was found to suppress the expression of UGT1A specifically in the urinary bladder. This suppression was counteracted by oltipraz in wild-type mice but not in Nrf2-/- mice. These results show that Nrf2 and its downstream target genes are responsible for BBN detoxification. Furthermore, oltipraz prevents carcinogenesis by BBN by enhancing detoxification of this carcinogen in the liver and urinary bladder.
Insights
Nuclear factor erythroid 2-related factor 2 (Nrf2) is crucial for detoxifying carcinogens like N-nitrosobutyl(4-hydroxybutyl)amine (BBN). The chemopreventive agent oltipraz enhances this detoxification, protecting against BBN-induced bladder cancer in mice.
Area of Science:
- Biochemistry
- Toxicology
- Cancer Prevention
Background:
- Phase 2 detoxifying enzymes, like UDP-glucuronosyltransferases (UGTs), protect against carcinogens.
- Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates the expression of these detoxifying enzymes.
- Oltipraz is a synthetic agent known to induce phase 2 enzymes.
Purpose of the Study:
- To investigate the role of Nrf2 in susceptibility to the urinary bladder carcinogen N-nitrosobutyl(4-hydroxybutyl)amine (BBN).
- To evaluate the chemopreventive efficacy of oltipraz in Nrf2-deficient mice exposed to BBN.
Main Methods:
- Utilized Nrf2-deficient (Nrf2-/-) and wild-type (WT) mice.
- Administered BBN to induce urinary bladder carcinoma.
- Assessed the chemopreventive effects of oltipraz on BBN-induced carcinogenesis and detoxification pathways.
Main Results:
- Nrf2-/- mice exhibited significantly higher incidence of urinary bladder carcinoma following BBN exposure compared to WT mice.
- Oltipraz induced BBN-detoxifying phase 2 enzymes in a Nrf2-dependent manner.
- Oltipraz reduced BBN-induced bladder cancer in WT mice but not in Nrf2-/- mice, by enhancing BBN glucuronidation and counteracting UGT1A suppression.
Conclusions:
- Nrf2 and its downstream genes are essential for the detoxification of BBN.
- Oltipraz exerts chemopreventive effects against BBN-induced carcinogenesis by enhancing carcinogen detoxification in an Nrf2-dependent manner.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cancer Prevention
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase